The startup develops wound dressings that utilize patented nanotechnology, combining silver nanoparticles with other components to enhance antibacterial efficacy. This technology effectively inactivates a wider range of bacteria, including drug-resistant strains, addressing the challenge of treating infected wounds more effectively than traditional silver-based dressings.
Funding
€6.1M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
AEMESHF+2Founders
Product
Problem
Chronic wounds, including diabetic foot ulcers, affect millions worldwide and are increasingly prevalent due to aging populations and rising rates of diabetes and obesity. Current treatments often fail to heal these wounds effectively, leading to infections, amputations, and high mortality rates.
Solution
Nanordica Medical offers advanced antibacterial wound dressings utilizing Premotiv™ nanotechnology to simultaneously prevent infection and promote wound closure. The dressings feature a unique composition of silk nanofibers and synergistic copper and silver nanoparticles. This combination achieves superior antibacterial efficacy compared to traditional silver-based products, even against antibiotic-resistant strains, while remaining safe for skin cells. The nanofiber scaffold supports cell growth and facilitates wound healing.
Target Audience
The primary target audience includes healthcare providers specializing in wound care, podiatrists, surgeons, and hospitals treating patients with chronic wounds, diabetic foot ulcers, surgical wounds, and traumatic wounds.
Features
- Patented Premotiv™ nanotechnology combining copper and silver nanoparticles for enhanced antibacterial action
- Natural silk nanofibers that mimic the extracellular matrix to support cell adhesion and proliferation
- Demonstrated up to 8x better antibacterial efficacy than silver-based dressings in laboratory testing
- Shown to reduce wound area size twice as fast as silver-based dressings in a randomized controlled clinical trial with diabetic foot ulcers
- Broad-spectrum antimicrobial activity against gram-positive and gram-negative bacteria, including antibiotic-resistant strains
- Available in various sizes, both adhesive and non-adhesive
- Does not contain traditional antibiotics